$NYMXF Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$NYMXF SEC Filings

Filing Filed On
AMENDMENT NO. 6 TO FORM F-1, FILED ON FORM F-3 12 Mar 2003
FORM F-1 AMENDMENT NO. 5 30 Jul 2002
POST EFFECTIVE AMENDMENT #4 09 Nov 2001
POST-EFFECTIVE AMENDMENT 3 - NYMOX PHARMACEUTICAL 10 Aug 2001
POST EFFECTIVE AMENDMENT #2 15 May 2001
POST EFFECTIVE AMENDMENT NO. 1 08 May 2001